Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
EKSO BIONICS HOLDINGS, INC. amended term loan with Pacific Western Bank at the greater of (A) the Lender's "prime rate" then in effect and (B) 4.50% maturing August 13, 2026.
- Instrument
- term loan
- Counterparty
- Pacific Western Bank
- Rate
- the greater of (A) the Lender's "prime rate" then in effect and (B) 4.50%
- Maturity
- August 13, 2026
- Event
- amendment
Exact text from the filing
The Amendment amends that certain Loan and Security Agreement dated as of August 13, 2020, by and between the Borrower and the Lender to, among other things, (i) have daily borrowings under the Term Loan bear interest at a variable annual rate equal to the greater of (A) the Lender's "prime rate" then in effect and (B) 4.50%, (ii) cause the Borrower to maintain all of its depository, operating, and investment accounts with Lender and (iii) extend the Term Loan Maturity Date to August 13, 2026.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
EKSO BIONICS HOLDINGS, INC. amended Fifth Amendment to Loan and Security Agreement with Pacific Western Bank (effective 2023-08-17).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- Pacific Western Bank
- Effective
- 2023-08-17
Exact text from the filing
On August 17, 2023, Ekso Bionics Holdings, Inc. (the “Company”), Ekso Bionics, Inc., the Company’s wholly owned subsidiary (“Ekso Bionics” and, together with the Company, the “Borrower”) and Pacific Western Bank (the “Lender”), entered into the Fifth Amendment to Loan and Security Agreement (the “Amendment”).
View on SEC.gov